Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease

Author： Bobba Raja S.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.29, Iss.12, 2006-01, pp. : 1133-1152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety Considerations with Bisphosphonates for the Treatment of Osteoporosis

By Strampel William  

Drug Safety, Vol. 30, Iss. 9, 2007-01 ,pp. : 755-763

Adis International

Access to resources Recommend Favorite

Bisphosphonates as Treatment of Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1262-1271

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis: A Comparative Review

By Kherani R.B.   Papaioannou A.   Adachi J.D.  

Drug Safety, Vol. 25, Iss. 11, 2002-01 ,pp. : 781-790

Adis International

Access to resources Recommend Favorite

Bone Physiology, Disease and Treatment: Towards Disease System Analysis in Osteoporosis

By Post Teun M.  

Clinical Pharmacokinetics, Vol. 49, Iss. 2, 2010-02 ,pp. : 89-118

Adis International

Access to resources Recommend Favorite

Combined Therapies of Bone Disease with Bisphosphonates

By  

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-09 ,pp. : 2988-2997

Bentham Science Publishers

Access to resources Recommend Favorite